SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing an intense, sustained short squeeze, with community discussion highlighting a massive supply-demand mismatch where over 100% of the float is effectively locked by institutional holders. Traders are debating whether this parabolic move will continue toward extreme price targets or face a catastrophic rug pull, with many wary of the potential for a secondary offering or sudden regulatory intervention.

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is seeing significant upward momentum as investors react positively to finalized Medicare Advantage rates and a broader push for operational efficiency through AI and cost-cutting measures. The community is actively debating the stock's turnaround potential, with many bulls interpreting the recent price action as a sign of institutional accumulation and a long-term recovery ahead of upcoming earnings.

"What's Updog?" is a Community Led token.

UpDog

The UpDog community is rallying around the ticker through high-engagement social media campaigns and coordinated community events like poker tournaments, emphasizing a long-term 'trenches' narrative. Investors are actively discussing the project's ecosystem, memes, and the potential for collective retail buying power to drive momentum.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors monitor the company's global expansion into Japan, with sentiment heavily focused on potential international partnerships and a pending U.S. FDA approval for its immunotherapy platform. The community is actively discussing the stock's significant short interest and the hope for upcoming catalysts to drive a breakout in valuation.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending as investors react to a short-seller report that appears to have galvanized the community, leading to heavy buying volume and speculation regarding a potential short squeeze. Discussion is focused on the company's strategic move to redomicile in the U.S., its alignment with major semiconductor players in the AI infrastructure space, and technical momentum suggesting a retest of recent price levels.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as investors monitor potential partnerships and the integration of its power chip technology into AI data center infrastructure. The community remains divided, with some highlighting the company's long-term growth potential and institutional backing, while others express concern over valuation, persistent losses, and potential volatility ahead of upcoming earnings.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: Cybersecurity, Internet of Things (IoT), and Licensing and Other. The Cybersecurity segment includes the brand Cylance, BlackBerry Spark, AtHoc, and SecuSUITE. The IoT segment focuses on software licenses, support, maintenance, and professional services. The Licensing and Other segment involves the intellectual property licensing arrangements and settlement awards. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing a significant surge in investor interest and trading volume, driven by the expansion of its partnership with Nvidia to integrate QNX software into advanced edge AI and robotics platforms. The community is actively discussing the stock's potential for a major revaluation, with many long-term shareholders framing the news as a validation of the company's turnaround and its strategic shift toward becoming a foundational player in physical AI.

Applied Digital Corporation

Applied Digital is trending as investors closely monitor potential hyperscaler lease announcements tied to upcoming financing deadlines and executive compensation filings. The community remains highly focused on cryptic leadership communications and the potential for a major infrastructure partnership, despite broader market volatility and geopolitical concerns weighing on the sector.

Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, and Diagnostics. The Biotechnology segment includes bioprocessing, discovery, and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.

Danaher Corp.

Danaher Corp is currently a primary focus for investors as the company prepares for upcoming earnings, with active market discussion centered on bioprocessing recovery trends and potential institutional repositioning. Analysts and the community are closely monitoring recent price target adjustments and strategic M&A integration, debating whether Danaher's valuation reflects its long-term potential as a healthcare compounder or lingering cyclical headwinds.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is facing intense downward pressure driven by ongoing shareholder dilution, concerns over capital burn, and skepticism surrounding its ability to scale production profitably. While some community members point to Uber's increased stake and long-term production potential as reasons to hold, many are vocal about the stock's significant decline from its all-time highs and fear further equity offerings or reverse splits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month High  - Here's What Happened

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 1-Year High - Here's Why...

Can Myqorzo Drive Growth for Cytokinetics Amid Competition?

CYTK enters the commercial stage with FDA-approved Myqorzo for oHCM, eyeing strong market share, but faces stiff competition and execution risks.

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 1-Year High - Still a Buy?

Edgewise Therapeutics (NASDAQ:EWTX) Hits New 12-Month High - Here's Why...

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 12-Month High - Should You Buy?

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month High - Here's Why...

Aberdeen Group plc Increases Position in Edgewise Therapeutics, Inc. $EWTX

Aberdeen Group plc lifted its holdings in Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 32.6% during the fourth quarter, according to its most recent 13F filing with the Securities...

Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Recommendation of "Moderate Buy" by Analysts

Shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) have been given an average rating of "Moderate Buy" by the ten research firms that are currently covering the company, MarketBeat...

SG Americas Securities LLC Buys 78,842 Shares of Edgewise Therapeutics, Inc. $EWTX

SG Americas Securities LLC raised its position in shares of Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Free Report) by 797.9% during the fourth quarter, according to its most recent Form 13F filing...

Edgewise Therapeutics (NASDAQ:EWTX) CMO Sells $926,069.22 in Stock

Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) CMO Joanne Donovan sold 28,662 shares of the company's stock in a transaction on Wednesday, April 1st. The shares were sold at an average...

Edgewise Therapeutics (NASDAQ:EWTX) CMO Joanne Donovan Sells 28,662 Shares

Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) CMO Joanne Donovan sold 28,662 shares of the business's stock in a transaction dated Wednesday, April 1st. The stock was sold at an average...

Edgewise Therapeutics (NASDAQ:EWTX) Sets New 52-Week High - Here's What Happened

Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week High - Should You Buy...

Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders for which there is significant unmet medical need. Its platform utilizes custom-built throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue, initially focused on addressing rare neuromuscular and cardiac diseases. The company was founded by Badreddin Edris, Alan Russel and Peter A. Thompson in 2017 and is headquartered in Boulder, CO.

Fiscal Period	Estimated	Reported	Surprise	Result
Q1 '26	-$0.49	--	--	N/A
Q4 '25	-$0.43	-$0.47	-8.48%	MISSED
Q3 '25	-$0.40	-$0.39	1.86%	BEAT
Q2 '25	-$0.41	-$0.34	17.91%	BEAT
Q1 '25	-$0.43	-$0.43	-0.45%	MISSED

EWTX
Edgewise Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q1 '26

Historical Earnings

Latest EWTX News

EWTXEdgewise Therapeutics Inc